Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Corbus Pharmaceuticals (DE:337)
FRANKFURT:337
RESEARCH TOOLSreports
Corbus Pharmaceuticals (337) Ownership - Who Owns Corbus Pharmaceuticals?
0 Followers
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Aug 12, 2022 | Bought | $1250 | |
| Aug 11, 2022 | Yuval Cohen Ceo,director | Bought | $988 |
| Aug 10, 2022 | Sean Moran Cfo | Bought | $5000 |
| May 16, 2022 | Yuval Cohen Ceo,director | Bought | $2625 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Corbus Pharmaceuticals (DE:337)?
Currently, no data Available
What percentage of Corbus Pharmaceuticals (DE:337) stock is held by institutional investors?
Currently, no data Available
What percentage of Corbus Pharmaceuticals (DE:337) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Corbus Pharmaceuticals (DE:337)?
Currently, no data Available
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.